ALB and neoplasm: In contrast, replacing the AMBA linker with a more hydrophilic D-glutamate residue compromised the albumin-binding properties and, hence, led to the typical characteristics of folate radioconjugates without an albumin binder, namely moderate tumor uptake and high renal accumulation [23].